Chor S. Chim
University of Hong Kong
62 Papers
761 Citations
Chor S. Chim is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Medicine & DNA methylation. The author has an hindex of 23, co-authored 62 publications. Previous affiliations of Chor S. Chim include Queen Mary University of London.
Chat about Author
Papers
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
C. Fernández de Larrea,Robert A. Kyle,Brian G.M. Durie,Heinz Ludwig,Saad Z. Usmani,David H. Vesole,Roman Hájek,J F San Miguel,O. Sezer,Pieter Sonneveld,Shaji Kumar,Anuj Mahindra,Raymond L. Comenzo,Antonio Palumbo,A. Mazumber,KC Anderson,P. G. Richardson,Ashraf Badros,Jo Caers,Michele Cavo,Xavier Leleu,Meletios A. Dimopoulos,Chor S. Chim,Rik Schots,A. Noeul,Dorotea Fantl,Ulf-Henrik Mellqvist,Ola Landgren,Asher Chanan-Khan,Philippe Moreau,Rafael Fonseca,Giampaolo Merlini,J. J. Lahuerta,J. Bladé,Robert Z. Orlowski,Jatin J. Shah +35 more
TL;DR: It is proposed that the thresholds for diagnosis be re-examined and consensus recommendations are made for diagnosis, as well as, response and progression criteria.
361
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
Chor S. Chim,Shaji Kumar,Robert Z. Orlowski,Gordon Cook,P. G. Richardson,Morie A. Gertz,Sergio Giralt,M.V. Mateos,Xavier Leleu,Kenneth Anderson +9 more
TL;DR: Clinical trial data of next generation proteasome inhibitors, next-generation immunomodulatory agent, and monoclonal antibodies approved for relapsed and refractory multiple myeloma are summarized, cautious interpretation of RCTs highlighted, and algorithm for salvage treatment of relapse/refractory MM proposed.
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.
Artur Jurczyszyn,Norbert Grzasko,Norbert Grzasko,Alessandro Gozzetti,Jacek Czepiel,Alfonso Cerase,Vania Hungria,Edvan de Queiroz Crusoe,Ana Luiza Miranda Silva Dias,Ravi Vij,Mark A. Fiala,Jo Caers,Leo Rasche,Ajay K. Nooka,Sagar Lonial,David H. Vesole,Sandhya Philip,Shane A Gangatharan,Agnieszka Druzd-Sitek,Jan Walewski,Alessandro Corso,Federica Cocito,Marie Christine M. Vekemans,Erden Atilla,Meral Beksac,Xavier Leleu,Julio Dávila,Ashraf Z. Badros,Ekta Aneja,Niels Abildgaard,Efstathios Kastritis,Dorotea Fantl,Natalia Schutz,Tomas Pika,Aleksandra Butrym,Magdalena Olszewska-Szopa,Lidia Usnarska-Zubkiewicz,Saad Z. Usmani,Hareth Nahi,Chor S. Chim,Chaim Shustik,Krzysztof Madry,Suzanne Lentzsch,Alina Swiderska,Grzegorz Helbig,Renata Guzicka-Kazimierczak,Nikoletta Lendvai,Anders Waage,Kristian Thidemann Andersen,Hirokazu Murakami,Sonja Zweegman,Jorge J. Castillo +51 more
TL;DR: Although prognosis is generally poor, the survival of previously untreated patients and patients with favorable cytogenetic profile might be prolonged due to systemic treatment and/or radiotherapy.
109
SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway
TL;DR: SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway.
77
Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance.
TL;DR: The frequency and prognostic significance of p15 and p16 gene methylation in adult acute leukemia is investigated and gene‐promoter methylation is investigated for its role in transcription inactivation.
75